Alligator Bioscience AB
F:7AL0
Alligator Bioscience AB
F:7AL0
Price:
0.0001
EUR
Market Closed
Market Cap:
€65.7k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Alligator Bioscience AB
F:7AL0
|
SE |
|
U
|
United Bank Ltd
KAR:UBL
|
PK |
|
AVITA Medical Inc
F:51KA
|
US |
|
Block Inc
F:SQ30
|
US |
|
Z
|
Zinc Media Group PLC
LSE:ZIN
|
UK |
|
G
|
Goldplat PLC
XBER:G7N
|
UK |
|
F
|
First Phosphate Corp
OTC:FRSPF
|
CA |
|
F
|
FACC AG
VSE:FACC
|
AT |
Wall St Price Targets
7AL0 Price Targets Summary
Alligator Bioscience AB
Alligator Bioscience AB
Wall Street analysts forecast 7AL0 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 7AL0 is 0.0007 EUR with a low forecast of 0.0007 EUR and a high forecast of 0.0007 EUR.
Lowest Forecast
Price Target
0.0007
EUR
618% Upside
Average Forecast
Price Target
0.0007
EUR
625% Upside
Highest Forecast
Price Target
0.0007
EUR
646% Upside
Alligator Bioscience AB Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 7AL0's stock price target?
Price Target
0.0007
EUR
0.0007
EUR
According to Wall Street analysts, the average 1-year price target for 7AL0 is 0.0007 EUR with a low forecast of 0.0007 EUR and a high forecast of 0.0007 EUR.
What is the Revenue forecast for Alligator Bioscience AB?
Projected CAGR
95%
95%
Over the last 10 years, the compound annual growth rate for Revenue has been -47%. The projected CAGR for the next 2 years is 95%.
